UK Royal Commission on nano
This article was originally published in The Rose Sheet
There is no evidence of environmental or health risks from nanomaterials, and thus no need for a ban or moratorium against nanotechnology, the U.K.'s Royal Commission on Environmental Pollution says in a report published Nov. 12. However, the independent advisory panel calls for more testing on the functionality of nanoparticles, the immediate establishment of a research program and more flexibility in government to address nanotechnology and other nascent fields. Sir John Lawton, commission chair, calls for extending the coverage of the EU's REACH chemical regulation to nanomaterials, as "the rate of innovation in this sector far outstrips our capacity to respond to the risks." The European Commission has advised EU members to refrain from research on nanoparticles in food and personal care items until more risk assessments are completed (1"The Rose Sheet" Feb. 18, 2008, p. 6)
You may also be interested in...
Researchers should avoid clinical studies on nano-based cosmetics until more is known about their long-term effects, according to a Recommendation issued Feb. 7 by the European Commission (EC)
Pain relief product sales grew 27% and upper respiratory sales 35% for the week ended 7 March as consumers respond to COVID-19, according to Nielsen data noted in a Jefferies report on consumer health purchasing trends. Private label market share is up slightly, while OTC purchases continue primarily in conventional stores.
Managing partner Corey Goodman said venBio didn’t have trouble closing its fund, because the venture capital firm prepared its investors for an economic downturn months ago.